Show simple item record

dc.contributor.advisorPaula T. Hammond and Robert Langer.en_US
dc.contributor.authorMacdonald, Mara Leeen_US
dc.contributor.otherHarvard University--MIT Division of Health Sciences and Technology.en_US
dc.date.accessioned2010-09-01T16:29:53Z
dc.date.available2010-09-01T16:29:53Z
dc.date.copyright2010en_US
dc.date.issued2010en_US
dc.identifier.urihttp://hdl.handle.net/1721.1/58091
dc.descriptionThesis (Ph. D.)--Harvard-MIT Division of Health Sciences and Technology, 2010.en_US
dc.descriptionPages 185-186 blank. Cataloged from PDF version of thesis.en_US
dc.descriptionIncludes bibliographical references (p. 171-184).en_US
dc.description.abstractThis thesis focuses on the use of ultrathin therapeutic protein delivery films to control host tissue/medical device implant interactions, thereby reducing complications that lead to implant failure. The Layer by Layer (LbL) deposition platform was used to fabricate conformal, tunable, micron scale reservoirs for the controlled release of a wide variety of proteins including enzymes, growth factors, and antibodies that were shown to be capable of directing cells in vitro to desired outcomes including proliferation, differentiation, and quiescence. Film release profiles were controlled through rational polymer design, tuning film composition, and varying film architecture. In studies with a model protein lysozyme, 100% retention of protein function was observed, underscoring gentle process conditions. In vitro experiments with Fibroblast Growth Factor-2 (FGF-2) and Bone Morphogenetic Protein -2 (BMP-2) showed that released growth factors are more active than growth factors supplemented in medium, suggesting a surface concentration mechanism and/or specific growth factor interactions with LbL film components. Anti-VEGF releasing LbL films afforded new opportunities to modify cancer therapy nanoparticles for multi therapeutic release, and provided an important switch to turn off the cellular response to growth factors. Using an orthopedic hip implant model as a test case, the first LbL film with enough growth factor load to direct in vivo host cell response was demonstrated. BMP-2 releasing LbL films were used to direct MC3T3 pre-osteoblast differentiation in vitro, and the differentiation of host mesenchymal stem cells in a rat quadriceps model in vivo to form bone tissue in a first generation model for remediating orthopedic hip implant complications. Preliminary data on second generation, multifunctional drug delivery films are promising. These studies contribute to the mechanistic design of protein LbL films and show promise for a wide variety of clinical applications, opening avenues for multifunctional drug delivery from LbL films.en_US
dc.description.statementofresponsibilityby Mara Lee Macdonald.en_US
dc.format.extent186 p.en_US
dc.language.isoengen_US
dc.publisherMassachusetts Institute of Technologyen_US
dc.rightsM.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.en_US
dc.rights.urihttp://dspace.mit.edu/handle/1721.1/7582en_US
dc.subjectHarvard University--MIT Division of Health Sciences and Technology.en_US
dc.titlePolyelectrolyte multilayer growth factor delivery : mediating tissue/device interactionsen_US
dc.typeThesisen_US
dc.description.degreePh.D.en_US
dc.contributor.departmentHarvard University--MIT Division of Health Sciences and Technology
dc.identifier.oclc655900188en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record